One of the advantages of ADSEP is that it can be used for a variety of purposes, as it can simultaneously process three cassettes and each can be monitored and controlled independently. Based on biological and physical research, it can also be used as a space factory in small quantities.
Application examples to date include fluid processing (bacterial research, uniform crystallization of biopharmaceuticals), separation (two-phase separation, microencapsulation), and cell culture (see "BFF's use as a cell culture device" below), live squid breeding, etc.

One example of its use is the BFF, which is an indispensable device for space bio-3D printers. BFF can print soft human tissue that would collapse under its own weight on Earth, but if you try to bring tissue printed in space back to Earth as is, the tissue will collapse. ADSEP is used to cultivate cell tissue printed with BFF and strengthen the tissue in order to maintain the tissue even after returning to Earth's gravity. The 3D printing process with BFF takes less than one day, while the cell enrichment process with ADSEP takes 12 to 45 days depending on the tissue.

First, we have a meeting with the experimenter to clarify the experimental requirements and hardware layout. We provide optimal hardware, leveraging existing hardware or building new hardware to meet the needs of experimenters. Several months before launch, verification experiments will be conducted on the ground to confirm that the experimental objectives are achieved. At the launch site, we will work with the experiment director to assemble flight hardware and arrange for delivery to launch personnel. (Usually, we will arrange for loading a few days before launch, which is called late loading.)

ADSEP has achieved the highest Technology Readiness Level of 9* as indicated by NASA.
As a recent achievement, in September 2023, successful 3D bioprinting of a human knee meniscus was accomplished on the ISS using ADSEP and BFF. This is a significant milestone aimed at improving the treatment of meniscus injuries among US Service Members. After 14 days of cultivation on the ISS, the bioprinted meniscus was delivered to Earth. On the CRS-29 resupply mission to the ISS in November 2023, Redwire launched research payloads focused on pharmaceutical drug development and regenerative medicine, including an experiment in bioprinting cardiac tissue.

* Level 9 is the highest level, meaning that the system is an actual system that has been "flight proven" through successful missions.

Redwire Corporation (NYSE: RDW), the company that provides ADSEP services, is headquartered in Jacksonville, Florida, USA. The company has operations in 10 locations and approximately 800 total employees in the U.S. and internationally. It is a global leader in mission critical space solutions and high reliability components for the next generation space economy, with valuable intellectual property for solar power generation, in-space 3D printing and manufacturing, avionics, critical components, sensors, digital engineering and space-based biotechnology. Redwire combines decades of flight heritage with an agile and innovative culture. The company’s “Heritage plus Innovation" strategy enables it to combine proven performance with new, innovative capabilities to provide its customers with the building blocks for the present and future of space infrastructure. Redwire has developed 20 payloads for human spaceflight vehicles, 10 are available for use today aboard the International Space Station.

Message from Redwire to Asia!
"While Redwire is headquartered in the U.S., and includes locations in Europe, it considers Asia one of its most important markets. The company is eager to partner on in-space research and manufacturing projects with universities, government agencies, and commercial companies in the region."

Source:
https://redwirespace.com/wp-content/uploads/2023/06/redwire-adsep-flysheet.pdf
https://www.issnationallab.org/ng18-bff-printer-redwire/
https://redwirespace.com/newsroom/four-biotechnologies-redwire-has-on-the-international-space-station-right-now/
https://redwirespace.com/newsroom/redwire-biofabrication-facility-successfully-prints-first-human-knee-meniscus-on-iss-paving-the-way-for-advanced-in-space-bioprinting-capabilities-to-benefit-human-health/